Table 3.
PAX2 loss in Adjacent Normal Endometrium | PAX2 loss in Simple Hyperplasia | ||||
---|---|---|---|---|---|
No/minimal loss | Partial loss | Complete loss | Total | ||
No/minimal loss | 6 | 5 | 4 | 15 | P=0.011 |
Partial loss | 0 | 4 | 0 | 4 | |
Complete loss | 0 | 0 | 0 | 0 | |
Total | 6 | 9 | 4 | 19 |
PAX2 loss in Complex Hyperplasia | |||||
---|---|---|---|---|---|
No/minimal loss | Partial loss | Complete loss | Total | ||
No/minimal loss | 3 | 2 | 32 | 56 | P<0.001 |
Partial loss | 0 | 4 | 12 | 16 | |
Complete loss | 0 | 0 | 0 | 0 | |
Total | 3 | 25 | 44 | 72 |
PAX2 loss in Atypical Hyperplasia | |||||
---|---|---|---|---|---|
No/minimal loss | Partial loss | Complete loss | Total | ||
No/minimal loss | 1 | 7 | 29 | 37 | P<0.001 |
Partial loss | 0 | 0 | 4 | 4 | |
Complete loss | 0 | 0 | 0 | 0 | |
Total | 1 | 7 | 33 | 41 |
PAX2 loss in FIGO Grade 1 Endometrial Cancer | |||||
---|---|---|---|---|---|
No/minimal loss | Partial loss | Complete loss | Total | ||
No/minimal loss | 0 | 2 | 10 | 12 | P=0.003 |
Partial loss | 0 | 0 | 0 | 0 | |
Complete loss | 0 | 0 | 0 | 0 | |
Total | 0 | 2 | 10 | 12 |
Stuart-Maxwell Test used to calculate P values